All terms in DRUGBANK

Label Id Description
8-oxo-dGMP DB02023
5'-O-(L-Threonylsulfamoyl)adenosine DB03355
DIMETHYL THIOPHOSPHATE DB04687
4-Amino-5-Hydroxymethyl-2-Methylpyrimidine DB02022
L-D-(a-Aminoadipoyl)-L-Cysteinyl-D-Valine DB02025
BIS(HEXAMETHYLENE)TRIAMINE DB04684
2-Iminobiotin DB03353
2-(Beta-D-Glucopyranosyl)-5-Methyl-1,3,4-Oxadiazole DB03354
3-phenylpropionic acid DB02024
1-{(2S,5S)-4-FLUORO-5-[(TRITYLOXY)METHYL]TETRAHYDROFURAN-2-YL}PYRIMIDINE-2,4(1H,3H)-DIONE DB04685
5-[(3AS,4R,6AR)-2-OXOHEXAHYDRO-1H-THIENO[3,4-D]IMIDAZOL-4-YL]PENTANOIC ACID DB04650
Ridinilazole DB15308 [Ridinilazole is under investigation in clinical trial NCT02092935 (A Study of SMT19969 Compared With Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhoea (CDAD)).]
Atabecestat DB15307 [Atabecestat is under investigation in clinical trial NCT02211079 (A Study to Assess Effect of JNJ-54861911 on Pharmacokinetics of Cocktail Representatives for Cytochrome P450 (CYP) 3A4, CYP2B6, CYP2C9, and CYP1A2 Substrates).]
iota-Carrageenan DB15304 [iota-Carrageenan is under investigation in clinical trial NCT01944631 (Iota-Carrageenan Nasal Spray in Common Cold).]
Faricimab DB15303 [Faricimab is under investigation in clinical trial NCT03823287 (A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Neovascular Age-Related Macular Degeneration (TENAYA)).]
MEDI-6469 DB15306 [MEDI-6469 is under investigation in clinical trial NCT02205333 (A Phase 1b/2 Safety and Tolerability of MEDI6469 in Combination With Therapeutic Immune Agents or Monoclonal Antibodies).]
Risdiplam DB15305 [Risdiplam is under investigation in clinical trial NCT03779334 (A Study of Risdiplam in Infants With Genetically Diagnosed and Presymptomatic Spinal Muscular Atrophy).]
Hydroquinidine DB15300 [Hydroquinidine is under investigation in clinical trial NCT00927732 (Hydroquinidine Versus Placebo in Patients With Brugada Syndrome).]
2-fluorofucose DB15302 [2-fluorofucose is under investigation in clinical trial NCT02952989 (A Safety Study of SGN-2FF for Patients With Advanced Solid Tumors).]
Bevifimod DB15301 [Bevifimod is under investigation in clinical trial NCT01749787 (Safety Study of PRTX-100 With Methotrexate or Leflunomide to Treat Active Rheumatoid Arthritis).]